Reimbursed Drugs with Alternative Payment Model in Turkey

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region

Background & Objectives: Biological disease-modifying antirheumatic drugs (bDMARDs) for the treatment of rheumatoid arthritis (RA) are not always accessible to all patients in accordance with international guidelines, partly owing to their high direct costs against a background of restricted healthcare budgets. This study compares the size of RA patient populations with access to reimbursed bDM...

متن کامل

Inventory model with composed shortage and permissible delay in payment linked to order quantity

In today’s business transactions, it is frequently observed that a customer is allowed some grace period (permissible delay in payment) before settling the account with the supplier or producer. This policy is advantageous both for the supplier and customer since supplier attracts more customers and customer does not have to pay any interest during this fixed period either. In this paper, the r...

متن کامل

A Multi-supplier Inventory Model with Permissible Delay in Payment and ‎Discount

‎This paper proposes a multi-supplier multi-product inventory model in which the suppliers have unlimited production capacity, allow delayed payment, and offer either an all-unit or incremental discount. The retailer can delay payment until after they have sold all the units of the purchased product. The retailer’s warehouse is limited, but the surplus can be stored in a rented warehouse at a...

متن کامل

Complementary and alternative medicine in multiple sclerosis: Payment policy perspectives.

This article identifies payment policy perspectives of the American Academy of Neurology's guideline on complementary and alternative medicine (CAM) in multiple sclerosis (MS). The guideline is a reliable repository of information for advocating or not recommending certain CAM treatments in MS. It eases the burden of searching for information on each separate CAM treatment. It frequently emphas...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2017

ISSN: 1098-3015

DOI: 10.1016/j.jval.2017.08.1832